Seminars in Oncology
Volume 35, Issue 2 , Pages 160-171, April 2008

Metastatic Disease to the Pancreas and Spleen

  • Shayna L. Showalter
  • ,
  • Eric Hager
  • ,
  • Charles J. Yeo

      Affiliations

    • Corresponding Author InformationAddress correspondence to Charles J. Yeo, MD, FACS, Department of Surgery, Thomas Jefferson University, 1015 Walnut St, Suite 620 Curtis Bldg, Philadelphia, PA 19107, USA.

Department of Surgery, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA.

Isolated metastases to the pancreas and spleen are a rare occurrence. When they are diagnosed, pancreatic metastases are most often from renal cell carcinoma, lung cancer, and breast cancer. The most common source of splenic metastases is gynecological in origin; the overwhelming majority is ovarian. If extensive staging studies reveal these metastases to be isolated, then curative resection may be warranted. This review will demonstrate that long-term survival may be achieved in patients with isolated metastases and a prolonged disease-free interval.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by the Thomas Jefferson Surgical Pancreatic Research Fund.

PII: S0093-7754(07)00277-1

doi:10.1053/j.seminoncol.2007.12.008

Seminars in Oncology
Volume 35, Issue 2 , Pages 160-171, April 2008